Factor VIII: Long-established role in haemophilia A and emerging evidence beyond haemostasis
Open Access
- 3 March 2019
- journal article
- review article
- Published by Elsevier BV in Blood Reviews
- Vol. 35, 43-50
- https://doi.org/10.1016/j.blre.2019.03.002
Abstract
No abstract availableFunding Information
- Michael Healy of Sudler
- Bayer Pharma AG, Leverkusen
This publication has 100 references indexed in Scilit:
- Pathophysiology of Vascular Remodeling in HypertensionInternational Journal of Hypertension, 2013
- Factor VIII inhibitors in hemophilia A: rationale and latest evidenceTherapeutic Advances in Hematology, 2012
- Past, present and future of hemophilia: a narrative reviewOrphanet Journal of Rare Diseases, 2012
- Endothelial von Willebrand factor regulates angiogenesisBlood, 2011
- Bone mineral density in haemophilia patientsThrombosis and Haemostasis, 2010
- Factor VIII-von Willebrand Factor Complex Inhibits Osteoclastogenesis and Controls Cell SurvivalJournal of Biological Chemistry, 2009
- Long‐term prophylaxis in severe haemophilia seems to preserve bone mineral densityHaemophilia, 2009
- Factor VIII accelerates proteolytic cleavage of von Willebrand factor by ADAMTS13Proceedings of the National Academy of Sciences of the United States of America, 2008
- Inactivity is a risk factor for low bone mineral density among haemophilic childrenBritish Journal of Haematology, 2008
- The Relationship of HIV Status, Type of Coagulation Disorder, and School Absenteeism to Cognition, Educational Performance, Mood, and Behavior of Boys with HemophiliaThe Journal of Genetic Psychology, 1996